Abstract
Causal mediation analysis aims to investigate the mechanism linking an exposure and an outcome. Dealing with the impact of unobserved confounders among the exposure, mediator and outcome has always been an issue of great concern. Moreover, when multiple mediators exist, this causal pathway intertwines with other causal pathways, making it more difficult to estimate of path-specific effects (PSEs). In this article, we propose a method (PSE-MR) to identify and estimate PSEs of an exposure on an outcome through multiple causally ordered and non-ordered mediators using Mendelian Randomization, when there are unmeasured confounders among the exposure, mediators and outcome. Additionally, PSE-MR can be used when pleiotropy exists, and can be implemented using only summarized genetic data. We also conducted simulations to evaluate the finite sample performances of our proposed estimators in different scenarios. The results show that the causal estimates of PSEs are almost unbiased with good coverage and Type I error properties. We illustrate the utility of our method through a study of exploring the mediation effects of lipids in the causal pathways from body mass index to cardiovascular disease.
Author summary A new method (PSE-MR) is proposed to identify and estimate PSEs of an exposure on an outcome through multiple causally ordered and non-ordered mediators using summarized genetic data, when there are unmeasured confounders among the exposure, mediators and outcome. Lipids play important roles in the causal pathways from body mass index to cardiovascular disease
- mediation analysis
- multiple mediators
- causally ordered mediators
- causally non-ordered mediators
- Mendelian randomization
- summarized genetic data
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
FX was supported by the National Natural Science Foundation of China (Grant 81773547) and Shandong Provincial Key Research and Development project (2018CXGC1210). HL was supported by the National Natural Science Foundation of China (Grant 82003557).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was not sought, because this study involved analysis of publicly available summary-level data from GWASs, and no individual-level data were used.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest None declared
Source of Funding FX was supported by the National Natural Science Foundation of China (Grant 81773547) and Shandong Provincial Key Research and Development project (2018CXGC1210). HL was supported by the National Natural Science Foundation of China (Grant 82003557).
Availability of data and materials GWAS summary data for BMI, Lipids and CVD are publicly available at https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files, http://lipidgenetics.org/ and http://www.cardiogramplusc4d.org/, respectively. Code to implement the method and reproduce all simulations and analyses is available on Github (https://github.com/hhoulei/PSEMR).
Ethics approval and consent to participate Ethical approval was not sought, because this study involved analysis of publicly available summary-level data from GWASs, and no individual-level data were used.
Authors’ contributions HL and FX conceived the study. LH, HL contributed to theoretical derivation with assistance from YY, XL and XS. LH, RY and YY contributed to the data simulation. LH, HL and SS contributed to the application. LH and HL wrote the manuscript with input from all other authors. All authors reviewed and approved the final manuscript.
Data Availability
GWAS summary data for BMI, Lipids and CVD are publicly available at https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files, http://lipidgenetics.org/ and http://www.cardiogramplusc4d.org/, respectively. Code to implement the method and reproduce all simulations and analyses is available on Github (https://github.com/hhoulei/PSEMR).